Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea
- PMID: 16890209
- DOI: 10.1016/j.bcp.2006.06.021
Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea
Abstract
Toll-like receptors (TLRs) play an important role in recognition of microbial components and induction of innate immunity. The microbial components trigger the activation of two downstream signaling pathways of TLRs; MyD88- and/or TRIF-dependent pathways leading to activation of NF-kappaB. (-)-Epigallocatechin-3-gallate (EGCG), a flavonoid found in green tea, is known to inhibit NF-kappaB activation induced by many pro-inflammatory stimuli. EGCG was shown to inhibit the activity of IKKbeta which is the key kinase in the canonical pathway for NF-kappaB activation in MyD88-dependent pathway of TLRs. However, it is not known whether EGCG inhibits TRIF-dependent pathway through which more than 70% of lipopolysaccharide (LPS)-induced genes are regulated. Therefore, we attempted to identify the molecular target of EGCG in TRIF-dependent pathways of TLR3 and TLR4. EGCG inhibited the activation of IFN regulatory factor 3 (IRF3) induced by LPS, poly[I:C], or the overexpression of TRIF. The inhibition of IRF3 activation by EGCG was mediated through the suppression of the kinase activity of TBK1. However, EGCG did not inhibit activation of IRF3 induced by overexpression of constitutively active IRF3. These results suggest that the molecular target of EGCG is TBK1 in TRIF-dependent signaling pathways of TLR3 and TLR4. Therefore, our results suggest that green tea flavonoids can modulate both MyD88- and TRIF-dependent signaling pathways of TLRs and subsequent inflammatory target gene expression.
Similar articles
-
Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin.Biochem Pharmacol. 2009 Apr 15;77(8):1391-400. doi: 10.1016/j.bcp.2009.01.009. Epub 2009 Jan 23. Biochem Pharmacol. 2009. PMID: 19426678
-
Selenium suppresses the activation of transcription factor NF-kappa B and IRF3 induced by TLR3 or TLR4 agonists.Int Immunopharmacol. 2008 Mar;8(3):495-501. doi: 10.1016/j.intimp.2007.12.008. Epub 2008 Jan 14. Int Immunopharmacol. 2008. PMID: 18279804
-
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.Nat Rev Immunol. 2007 May;7(5):353-64. doi: 10.1038/nri2079. Nat Rev Immunol. 2007. PMID: 17457343 Review.
-
Inhibition of homodimerization of Toll-like receptor 4 by curcumin.Biochem Pharmacol. 2006 Jun 28;72(1):62-9. doi: 10.1016/j.bcp.2006.03.022. Epub 2006 Apr 1. Biochem Pharmacol. 2006. PMID: 16678799
-
Toll-like receptor downstream signaling.Arthritis Res Ther. 2005;7(1):12-9. doi: 10.1186/ar1469. Epub 2004 Nov 30. Arthritis Res Ther. 2005. PMID: 15642149 Free PMC article. Review.
Cited by
-
Effects of garlic (Allium sativum L) and Citrullus colocynthis (L.) Schrad individually and in combination on male reproductive damage due to diabetes: suppression of the AGEs/RAGE/Nox-4 signaling pathway.BMC Complement Med Ther. 2024 Apr 5;24(1):149. doi: 10.1186/s12906-024-04402-8. BMC Complement Med Ther. 2024. PMID: 38581015 Free PMC article.
-
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes.Molecules. 2023 Oct 21;28(20):7209. doi: 10.3390/molecules28207209. Molecules. 2023. PMID: 37894687 Free PMC article. Review.
-
Foodomics-Based Approaches Shed Light on the Potential Protective Effects of Polyphenols in Inflammatory Bowel Disease.Int J Mol Sci. 2023 Sep 27;24(19):14619. doi: 10.3390/ijms241914619. Int J Mol Sci. 2023. PMID: 37834065 Free PMC article. Review.
-
Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.Front Endocrinol (Lausanne). 2023 Aug 28;14:1217165. doi: 10.3389/fendo.2023.1217165. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37701897 Free PMC article. Review.
-
Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations.Curr Res Food Sci. 2023 May 18;6:100521. doi: 10.1016/j.crfs.2023.100521. eCollection 2023. Curr Res Food Sci. 2023. PMID: 37266414 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous